Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
18.47
-0.88 (-4.55%)
Dec 24, 2024, 1:00 PM EST - Market closed
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $475.15 million as of December 24, 2024. Its market cap has increased by 356.87% in one year.
Market Cap
475.15M
Enterprise Value
270.60M
1-Year Change
356.87%
Ranking
Category
Stock Price
$18.47
Market Cap Chart
Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $475.15M, an increase of 100.65%. That is a compound annual growth rate of 8.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 469.40M | 338.69% |
| Dec 29, 2023 | 107.00M | -38.11% |
| Dec 30, 2022 | 172.90M | -54.54% |
| Dec 31, 2021 | 380.30M | 16.19% |
| Dec 31, 2020 | 327.30M | 185.35% |
| Dec 31, 2019 | 114.70M | 92.13% |
| Dec 31, 2018 | 59.70M | -72.75% |
| Dec 29, 2017 | 219.10M | -29.78% |
| Dec 30, 2016 | 312.00M | 31.76% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phathom Pharmaceuticals | 509.41M |
| Talkspace | 503.39M |
| Auna S.A. | 501.16M |
| EyePoint Pharmaceuticals | 498.14M |
| Terns Pharmaceuticals | 497.74M |
| Third Harmonic Bio | 488.43M |
| Verve Therapeutics | 485.97M |
| MeiraGTx Holdings | 480.64M |